Dr. Lindblad, has been with the EMMES Corporation for the past 18 year. He is the Chief Medical Officer and leads Pharmacovigilance and Regulatory Affairs at Emmes. He was a Medical Monitor for the CDC initiated Ebola vaccine clinical trial in Sierra Leone and for Multiple PATH initiated vaccine clinical trials in the US and internationally. He has also served as PI on multiple other projects and established medical monitoring, MedDRA coding, WHO drug coding, and a comprehensive safety reporting system through our electronic Data Capture System. Prior to joining Emmes, Dr. Lindblad served as Medical Officer at FDA, Center for Biologics and Evaluation Research, Division of Therapeutic Trials and Application, Branch of Immunology and Infectious Disease, reviewing multiple IND and BLA submission to the agency. In addition, Dr. Lindblad is board certified in Emergency Medicine with a career spanning over 30 years of practice in Bethesda, Maryland, Canton, Ohio, Chicago Illinois and Philadelphia, Pennsylvania.